Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

ICU Medical, Inc. ICUI

Healthcare  —  Medical Instruments & Supplies
164.95 (1.07) (0.64%) as of 25 Sep
Market cap
$4.2B
P/E
137×
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

ICU Medical, Inc. (ICUI) Business Profile

Updated before January 2025

Company Overview

ICU Medical, Inc. (ICUI) is a global leader in the development, manufacturing, and sale of innovative medical devices used in infusion therapy, oncology, and critical care applications. Founded in 1984 by Dr. George Lopez, the company is headquartered in San Clemente, California. ICU Medical began as a small startup focused on creating safer and more effective intravenous (IV) therapy systems. Over the years, the company has grown significantly through organic growth and strategic acquisitions, including the transformative acquisition of Hospira Infusion Systems from Pfizer in 2017. This acquisition expanded ICU Medical’s product portfolio and solidified its position as a key player in the infusion therapy market.

The company is led by a team of experienced executives, with Vivek Jain serving as Chairman and Chief Executive Officer (CEO). Under Jain’s leadership, ICU Medical has focused on innovation, operational efficiency, and global expansion to meet the evolving needs of healthcare providers and patients worldwide.

Core Business Segments

ICU Medical operates across several core business segments, offering a wide range of products and services designed to improve patient care and safety. These segments include:

1. Infusion Therapy

ICU Medical is renowned for its advanced infusion therapy solutions, which include IV sets, connectors, and pumps. Key products in this category include:

  • Plum 360 Infusion System: A state-of-the-art infusion pump designed for precise medication delivery and enhanced patient safety.
  • ChemoClave® and MicroClave® Connectors: Needle-free connectors that reduce the risk of bloodstream infections and improve healthcare worker safety.
  • IV Administration Sets: High-quality sets designed for reliable and efficient fluid delivery.

2. Oncology

The company offers specialized products for oncology care, focusing on the safe and effective delivery of chemotherapy drugs. Key offerings include:

  • ChemoLock® Closed System Transfer Devices (CSTDs): Designed to minimize exposure to hazardous drugs during preparation and administration.
  • Oncology Infusion Systems: Tailored solutions for the unique needs of cancer patients and healthcare providers.

3. Critical Care

ICU Medical provides critical care solutions that support the monitoring and treatment of patients in intensive care units (ICUs). Key products include:

  • Transpac® IV Monitoring Systems: Advanced systems for accurate hemodynamic monitoring.
  • Custom Critical Care Kits: Tailored kits that streamline workflows and improve efficiency in critical care settings.

4. IV Solutions

Following the acquisition of Hospira Infusion Systems, ICU Medical expanded its portfolio to include IV solutions. These products are essential for fluid and electrolyte replacement, medication delivery, and nutrition therapy.

Business Model

ICU Medical’s business model is centered on providing integrated solutions that enhance patient safety, improve clinical outcomes, and streamline healthcare workflows. The company generates revenue through the sale of medical devices, consumables, and related services. Key elements of its business model include:

  • Product Innovation: ICU Medical invests heavily in research and development (R&D) to create cutting-edge medical devices that address unmet clinical needs.
  • Strategic Partnerships: The company collaborates with healthcare providers, distributors, and other stakeholders to expand its market reach and improve customer satisfaction.
  • Recurring Revenue Streams: A significant portion of ICU Medical’s revenue comes from the sale of consumables and disposables, which are used in conjunction with its durable medical devices.
  • Global Presence: ICU Medical operates in multiple countries, leveraging its extensive distribution network to serve a diverse customer base.

Strategic Direction

ICU Medical is committed to driving growth and innovation while addressing the challenges facing the healthcare industry. Key strategic priorities include:

  • Expansion of Product Portfolio: The company aims to develop new products and enhance existing ones to meet the evolving needs of healthcare providers and patients.
  • Sustainability Goals: ICU Medical is focused on reducing its environmental footprint by adopting sustainable manufacturing practices and minimizing waste.
  • Geographic Expansion: The company plans to strengthen its presence in emerging markets, where demand for advanced medical devices is growing rapidly.
  • Digital Transformation: ICU Medical is exploring opportunities to integrate digital technologies, such as data analytics and connectivity, into its products and services to improve patient outcomes and operational efficiency.

Competitive Landscape

ICU Medical operates in a highly competitive market, facing competition from both large multinational corporations and smaller specialized companies. Key competitors include:

  • Baxter International: A global leader in infusion therapy and renal care products.
  • B. Braun Medical: Known for its comprehensive portfolio of infusion systems and IV therapy products.
  • Fresenius Kabi: A major player in the infusion therapy and clinical nutrition markets.
  • Smiths Medical: Specializes in infusion systems, vascular access, and critical care products.

ICU Medical differentiates itself through its focus on innovation, quality, and customer service, as well as its strong commitment to patient safety.

Risk Factors

Like any business, ICU Medical faces several risks that could impact its performance and growth prospects. Key risk factors include:

  • Market Dependence: The company’s revenue is heavily reliant on the sale of infusion therapy products, making it vulnerable to market fluctuations and competitive pressures.
  • Regulatory Compliance: As a medical device manufacturer, ICU Medical must comply with stringent regulatory requirements, which can be time-consuming and costly.
  • Supply Chain Disruptions: The company is exposed to risks related to supply chain disruptions, including shortages of raw materials and transportation delays.
  • Economic Uncertainty: Global economic conditions, including inflation and currency fluctuations, could impact ICU Medical’s financial performance.

Recent Developments

ICU Medical has made significant strides in recent years, including:

  • Product Innovations: The launch of new and improved infusion systems and connectors to enhance patient safety and clinical efficiency.
  • Strategic Acquisitions: The acquisition of Hospira Infusion Systems, which expanded the company’s product portfolio and market presence.
  • Global Expansion: Increased focus on emerging markets, particularly in Asia and Latin America, to drive growth.
  • Response to COVID-19: ICU Medical played a critical role during the pandemic by ensuring the availability of essential medical devices and supplies.

Investment Considerations

Investors considering ICU Medical should weigh the following strengths and risks:

Strengths

  • Strong market position in infusion therapy and oncology.
  • Robust product portfolio with a focus on patient safety and innovation.
  • Recurring revenue streams from consumables and disposables.
  • Experienced leadership team and commitment to operational excellence.

Risks

  • Dependence on a few key product categories for revenue.
  • Exposure to regulatory and compliance risks.
  • Vulnerability to supply chain disruptions and economic uncertainty.

Conclusion

ICU Medical, Inc. is a leading player in the medical device industry, with a strong focus on innovation, quality, and patient safety. The company’s comprehensive product portfolio, global presence, and commitment to sustainability position it well for future growth. While challenges such as regulatory compliance and supply chain risks remain, ICU Medical’s strategic initiatives and market leadership make it a compelling choice for healthcare providers and investors alike.